The results of the present candidate gene-driven association analysis show that CD5, CD6, and CD166/ALCAM genetic polymorphisms are associated with the clinical and analytical parameters of the disease in a local cohort of pSS patients. The gene discussed is ALCAM; the disease is peeling skin syndrome.